TAILIEUCHUNG - Pharmaceutical Substances Syntheses, Patents, Applications - Part 59

Pharmaceutical Substances Syntheses, Patents, Applications - Part 59. Reference containing a collection of 2267 active pharmaceutical ingredients, including those launched recently. Listed alphabetically according to their INNs and established a link between INNs, structure, synthesis and production processes, patent and literature situation, medical use, and trade names. For pharmacists and researchers | Defibrotide D 581 Formulation s amp. 500 mg inj. powder 500 mg lyo. 500 mg 2 g I Trade Nameisj D Desferal Ciba F Desférai Ciba-Geigy GB Desferal Novartis I Desferal Ciba-Geigy J Desferal Novartis-Takeda USA Desferal Novartis as mesylate Defibrotide ATC B0JAX01 B06A Use antithrombotic cholinergic channel modulator stimulates fibrinolysis RN 83712-60-1 MF unspecified MW unspecified I CN defibrotide polydeoxyribonucleotides from bovine lung Extraction from mammalian organs with aqueous solution of Zn salts. Reference s DE2 154 278 Crinos appl. I-prior. . f DE 2 154 277 Crinos appl. I-prior. . I US 3 829 567 Crinos I-prior. . í US3899481 Crinos I-prior. . EP263 155 Crinos I-prior. . medical use for renal dialysis patients EP317 766 Crinos appl. I-prior. . J medical use for treatment of myocardial ischaemia í EP 152 148 Crinos appl. I-prior. . medical use for treatment of peripheral arterial disease EP 137 543 Crinos appl. I-prior. . medical use for treatment of acute renal insufficiency EP 137 542 Crinos appl. I-prior. . Formulation s vial 200 mg Trade Name s I Dasovas Carlo Erba Noravid Roussel 1986 Proci elide Crinos 1986 Deflazacort atc 1102AB13 Azacort Oxazacort Use glucocorticoid anti-inflammatory RN 14484-47-0 MF C25H3INO6 MW EINECS 238-483-7 LD5 5200 mg kg M . CN 1 lp 16P -21- acetyloxy -l l-hydroxy-2 -methyl-577-pregna-l 4-dieno 17 16-J oxazole-3 20-dione 17a-azido-3 î 16a-di-ocetoxy-5a-pregnane-11 20-dione 3 J-hydroxy-2 -methyl-5a 5 ÎH-pregnano 17 16-d oxazole-11 20 dione 1 582 D Dehydrocholic acid 2. NaBH4 3. HCI 1. semicarbozide 1. AI OCH CH4 2 4. cyclohexanone O CH3 2. Br2 3. Li2CO5 Me1 N CH3 T -0 Me H 1. aluminum triisopropoxide I I H J H 2. bromine 3. lithium II carbonate Reference s GB 1 077 393 Lepetit appl. . Nathansohn G. et al. J. Med. Chem. JMCMAR 10 .

• Sinh học
• 2267 hoạt chất dược phẩm
• Sách nghiên cứu dược
• hoạt chất dược phẩm
• tổng hợp quá trình sản xuất
• sáng chế thuốc